BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28135562)

  • 1. Circulating Tumor Cells: Fluid Surrogates of Solid Tumors.
    Thiele JA; Bethel K; Králíčková M; Kuhn P
    Annu Rev Pathol; 2017 Jan; 12():419-447. PubMed ID: 28135562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells: Overview and Opportunities in Cytology.
    Sundling KE; Lowe AC
    Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies on circulating and disseminated tumor cells in carcinoma patients.
    Alix-Panabières C; Bartkowiak K; Pantel K
    Mol Oncol; 2016 Mar; 10(3):443-9. PubMed ID: 26847851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical indications for, and the future of, circulating tumor cells.
    Moon DH; Lindsay DP; Hong S; Wang AZ
    Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of circulating tumor cells in gastric cancer patients.
    Zhou J; Ma X; Bi F; Liu M
    Oncotarget; 2017 Apr; 8(15):25713-25720. PubMed ID: 28147337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells: High-Throughput Imaging of CTCs and Bioinformatic Analysis.
    Keomanee-Dizon K; Shishido SN; Kuhn P
    Recent Results Cancer Res; 2020; 215():89-104. PubMed ID: 31605225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.
    Alix-Panabières C; Pantel K
    Expert Rev Mol Diagn; 2015; 15(11):1411-7. PubMed ID: 26390240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress in the clinical use of circulating tumor cells as prognostic biomarkers.
    Jin KT; Chen XY; Lan HR; Wang SB; Ying XJ; Abdi SM; Wang W; Hu ZM; Mou XZ
    Cancer Cytopathol; 2019 Dec; 127(12):739-749. PubMed ID: 31589381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.
    Zhang WW; Rong Y; Liu Q; Luo CL; Zhang Y; Wang FB
    Clin Transl Oncol; 2019 Jul; 21(7):828-835. PubMed ID: 30569214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells in prostate cancer: beyond enumeration.
    Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application.
    Cortés-Hernández LE; Eslami-S Z; Pantel K; Alix-Panabières C
    Clin Chem; 2020 Jan; 66(1):97-104. PubMed ID: 31811001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer.
    Liu M; Tang M; Li M; Gao F; Shi C; Hou J; Zeng W
    Anticancer Agents Med Chem; 2016; 16(12):1529-1540. PubMed ID: 26902602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.